196 related articles for article (PubMed ID: 38619287)
1. Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Nakashoji A; Haratake N; Bhattacharya A; Mao W; Xu K; Wang K; Daimon T; Ozawa H; Shigeta K; Fushimi A; Yamashita N; Morimoto Y; Shimokawa M; Saito S; Egloff AM; Uppaluri R; Long MD; Kufe D
Cancer Res Commun; 2024 May; 4(5):1268-1281. PubMed ID: 38619287
[TBL] [Abstract][Full Text] [Related]
2. Mucin 1 regulates the hypoxia response in head and neck cancer cells.
Utispan K; Koontongkaew S
J Pharmacol Sci; 2021 Dec; 147(4):331-339. PubMed ID: 34663515
[TBL] [Abstract][Full Text] [Related]
3. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
4. MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.
Huang TQ; Bi YN; Cui Z; Guan JP; Huang YC
Bioengineered; 2020 Dec; 11(1):769-778. PubMed ID: 32662743
[TBL] [Abstract][Full Text] [Related]
5. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
[TBL] [Abstract][Full Text] [Related]
6. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
7. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
[TBL] [Abstract][Full Text] [Related]
8. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
[TBL] [Abstract][Full Text] [Related]
9. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
Ma H; Jin S; Yang W; Zhou G; Zhao M; Fang S; Zhang Z; Hu J
Br J Cancer; 2018 Feb; 118(4):509-521. PubMed ID: 29348488
[TBL] [Abstract][Full Text] [Related]
13. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
Lakshmanachetty S; Balaiya V; High WA; Koster MI
Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
[TBL] [Abstract][Full Text] [Related]
14. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
15. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
16. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.
Fukusumi T; Guo TW; Ren S; Haft S; Liu C; Sakai A; Ando M; Saito Y; Sadat S; Califano JA
Int J Oncol; 2021 Feb; 58(2):226-237. PubMed ID: 33491747
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
[TBL] [Abstract][Full Text] [Related]
19. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
[TBL] [Abstract][Full Text] [Related]
20. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
